Clover Corporation Ltd
ASX:CLV
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.36
0.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Clover Corporation Ltd
Clover Corporation Ltd
Income from Continuing Operations
Clover Corporation Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Clover Corporation Ltd
ASX:CLV
|
Income from Continuing Operations
AU$1.5m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
5%
|
|
|
Hazer Group Ltd
ASX:HZR
|
Income from Continuing Operations
-AU$19.1m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
Titomic Ltd
ASX:TTT
|
Income from Continuing Operations
-AU$11.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
First Graphene Ltd
ASX:FGR
|
Income from Continuing Operations
-AU$5.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-11%
|
|
|
Leaf Resources Ltd
ASX:LER
|
Income from Continuing Operations
-AU$8.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Advance ZincTek Ltd
ASX:ANO
|
Income from Continuing Operations
-AU$903k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Clover Corporation Ltd
Glance View
Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company is headquartered in Melbourne, Victoria and currently employs 53 full-time employees. The Company’s geographical segments include Australia/New Zealand, Asia, Europe and America. The firm is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. The company focuses on developing nutrients for use in foods or as nutritional supplements. The firm provides lipid-based ingredients for the food industry. The company focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. The company uses tuna oil, which has docosahexaenoic acid (DHA) for brain, nerve and eye tissue development in babies and infants. The company has a technology license for the encapsulation of marine and algal oils. The firm has a manufacturing plant for tuna oils and related products in Altona, Victoria.
See Also
What is Clover Corporation Ltd's Income from Continuing Operations?
Income from Continuing Operations
1.5m
AUD
Based on the financial report for Jul 31, 2024, Clover Corporation Ltd's Income from Continuing Operations amounts to 1.5m AUD.
What is Clover Corporation Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
5%
Over the last year, the Income from Continuing Operations growth was -76%. The average annual Income from Continuing Operations growth rates for Clover Corporation Ltd have been -37% over the past three years , -32% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
